If Gcar had read the quarterly
He would not have posted " there is no quarterly guidance"
The rest of us know they are targeting 40kT to 45kT in Q1
If the Spodumene price keeps falling at the current rate
..$1.50 is a certainty
If they go it alone in South America
...$1.50 is a certainty.
Cheers